| Mackenzie Erin Reffert, | |
|
555 N Duke St, Lancaster, PA 17602-2250 | |
| (717) 544-8200 | |
| Not Available |
| Full Name | Mackenzie Erin Reffert |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 555 N Duke St, Lancaster, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023775822 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LG0600X | Nurse Practitioner - Gerontology | SP024695 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lancaster General Hospital | Lancaster, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Heart Group Of Lancaster General Health | 1052507449 | 58 |
News Archive
Eighty designers, developers and medical experts from around the world will gather in Glasgow to solve the most pressing technology issues in medical education during AMEE Hacks, a 48-hour hackathon presented by the Association for Medical Education in Europe (AMEE).
Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory have identified tissue mechanisms that may influence a woman's susceptibility or resistance to breast cancer after exposure to low-dose ionizing radiation, such as the levels used in full-body CT scans and radiotherapy.
A large multicenter randomized clinical trial reported that supplementation with calcium and vitamin D did not reduce breast cancer risk in the overall population.
The U.S. Food and Drug Administration today granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration known as FGFR3 or FGFR2, and that has progressed during or following prior platinum-containing chemotherapy.
› Verified 4 days ago
| Entity Name | The Heart Group Of Lancaster General Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760793210 PECOS PAC ID: 1052507449 Enrollment ID: O20101124000695 |
News Archive
Eighty designers, developers and medical experts from around the world will gather in Glasgow to solve the most pressing technology issues in medical education during AMEE Hacks, a 48-hour hackathon presented by the Association for Medical Education in Europe (AMEE).
Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory have identified tissue mechanisms that may influence a woman's susceptibility or resistance to breast cancer after exposure to low-dose ionizing radiation, such as the levels used in full-body CT scans and radiotherapy.
A large multicenter randomized clinical trial reported that supplementation with calcium and vitamin D did not reduce breast cancer risk in the overall population.
The U.S. Food and Drug Administration today granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration known as FGFR3 or FGFR2, and that has progressed during or following prior platinum-containing chemotherapy.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mackenzie Erin Reffert, 1949 William Penn Way, Lancaster, PA 17601-5886 Ph: (412) 983-1766 | Mackenzie Erin Reffert, 555 N Duke St, Lancaster, PA 17602-2250 Ph: (717) 544-8200 |
News Archive
Eighty designers, developers and medical experts from around the world will gather in Glasgow to solve the most pressing technology issues in medical education during AMEE Hacks, a 48-hour hackathon presented by the Association for Medical Education in Europe (AMEE).
Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory have identified tissue mechanisms that may influence a woman's susceptibility or resistance to breast cancer after exposure to low-dose ionizing radiation, such as the levels used in full-body CT scans and radiotherapy.
A large multicenter randomized clinical trial reported that supplementation with calcium and vitamin D did not reduce breast cancer risk in the overall population.
The U.S. Food and Drug Administration today granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration known as FGFR3 or FGFR2, and that has progressed during or following prior platinum-containing chemotherapy.
› Verified 4 days ago
Ashley N Draper, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 540 N Duke St, Suite 110, Lancaster, PA 17602 Phone: 717-544-4995 Fax: 717-544-4944 | |
Laura Boll, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 540 N Duke St, 3rd Floor, Lancaster, PA 17602 Phone: 717-544-4950 | |
Rebecca Amy Nehring, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 625 S Duke St, Lancaster, PA 17602 Phone: 717-299-6371 Fax: 717-397-8881 | |
Ms. Ann L Rutt, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 685 Good Dr, Lancaster, PA 17601 Phone: 717-295-3900 | |
Mrs. Cindy L Zedaker, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1600 Cloister Dr, Lancaster, PA 17601 Phone: 717-391-7092 Fax: 717-735-2069 | |
Mrs. Jessica Ashley Quirin, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2110 Harrisburg Pike, Lancaster, PA 17601 Phone: 610-413-5335 | |
Ahblah Lopez, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2106 Harrisburg Pike # 1, Lancaster, PA 17601 Phone: 717-291-5931 |